- Coordinator
- European Infrastructure of Open Screening Platforms for Chemical Biology European Research Infrastucture Consortium (eu-Openscreen Eric), Germany
- Runs
- 1 March 2024 to 28 February 2027
- Status
- Running
- EU funding
- €4.0m
- Total cost
- €5.0m
- Partners
- 25 organisations in 10 countries
- Type
- Research and Innovation Action
- Grant agreement
- 101132028
What the project is doing
In the project's own words, from its summary on CORDIS.
EU-OPENSCREEN (EU-OS), the distributed European Research Infrastructure for Chemical Biology and early drug discovery, provides world-class services in high-throughput compound screening and medicinal chemistry to users from academia and industry. As one of the largest open-access initiative globally, EU-OPENSCREEN plays an increasingly important role in facilitating early stage drug discovery in Europe. It recently integrated fragment-based drug discovery and chemoproteomics as two new services, but the increasing complexity of modern drug discovery projects requires an even more comprehensive portfolio and integration of emerging technologies.
To ensure that EU-OS continues to offer a comprehensive suite of relevant services and support a growing user community to conduct forefront research, IMPULSE will develop, validate and integrate new services in AI/ML, new chemical modalities, and innovative disease-relevant cell models combined with CRISPR-Cas9/RNAi-based genetic screening. IMPULSE will work towards the implementation of common operational and data standards to increase data reproducibility and FAIRness.
Bespoke outreach and training activities will raise awareness among key user groups of its new services and advance operational excellence and reproducibility in pre-clinical drug discovery. New models for pre-competitive drug discovery with industry or charities, and growing ERIC member community will reinforce the sustainability and accessibility of EU-OPENSCREEN.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| European Infrastructure of Open Screening Platforms for Chemical Biology European Research Infrastucture Consortium (eu-Openscreen Eric) | Berlin | Germany | Coordinator |
| Masarykova univerzita | Brno | Czechia | Participant |
| Univerzita Palackeho V Olomouci | Olomouc | Czechia | Participant |
| Ustav Molekularni Genetiky Av Cr V.v.i. | Praha 4 | Czechia | Participant |
| Forschungsverbund Berlin eV | Berlin | Germany | Participant |
| Fraunhofer Gesellschaft Zur Forderung Der Angewandten Forschung eV | Munchen | Germany | Participant |
| Helmholtz-Zentrum Fur Infektionsforschung GmbH | Braunschweig | Germany | Participant |
| Danmarks Tekniske Universitet | Kongens Lyngby | Denmark | Participant |
| Agencia Estatal Consejo Superior De Investigaciones Cientificas | Madrid | Spain | Participant |
| Fundacion Centro De Excelencia En Investigacion De Medicamentos Innovadores En Andalucia | Armilla Granada | Spain | Participant |
| Fundacion De La Comunidad Valenciana Centro De Investigacion Principe Felipe | Valencia | Spain | Participant |
| Universidad De Santiago De Compostela | Santiago De Compostela | Spain | Participant |
| Helsingin Yliopisto | Helsinki | Finland | Participant |
| Turun Yliopisto | Turku | Finland | Participant |
| Valsts zinatniskais instituts ""Nacionalais petniecibas un inovaciju instituts"""" | Riga | Latvia | Participant |
| Universitetet I Bergen | Bergen | Norway | Participant |
| Universitetet I Oslo | Oslo | Norway | Participant |
| Instytut Biochemii I Biofizyki Polskiej Akademii Nauk | Warszawa | Poland | Participant |
| Instytut Biologii Medycznej Polskiej Akademii Nauk | Lodz | Poland | Participant |
| Instytut Chemii Bioorganicznej Polskiej Akademii Nauk | Poznan | Poland | Participant |
| Faculdade de Farmácia da Universidade de Lisboa | Lisboa | Portugal | Participant |
| I3s - Instituto De Investigacao E Inovacao Em Saude Da Universidade Do Porto | Porto | Portugal | Participant |
| Universidade De Coimbra | Coimbra | Portugal | Participant |
| Universidade Do Porto | Porto | Portugal | Participant |
| Karolinska Institutet | Stockholm | Sweden | Participant |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI